Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(2)
About
Glenmark Pharmaceuticals Ltd.
NSE: GLENMARK
|
BSE: 532296
|
ISIN: INE935A01035
|
Industry: Pharmaceuticals
|
Strong Performer, Getting Expensive
2170.7000
-85.70
(
-3.80
%)
NSE
Mar 13, 2026
15:31 PM
New 52W High in past week
Volume:
516.5K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Glenmark Pharmaceuticals Ltd.
24 Dec 2024
2170.70
-3.80%
GLENMARK PHARMACEUTICALS
Accumulate:
Glenmark Pharmaceuticals Ltd.
by
Geojit BNP Paribas
Target: 1720
Target
Geojit BNP Paribas
Number of FII/FPI investors increased from 401 to 422 in Dec 2025 qtr.
More from Glenmark Pharmaceuticals Ltd.
Recommended
Five Interesting Stocks Today - March 13, 2026
The Baseline |
13 Mar 2026
India is (finally) opening up to the world
The Baseline |
13 Mar 2026
Earnings Call Transcript - Q4FY20 for Glenmark Pharmaceuticals
|
29 Jun 2020